Bio Spectrum Magazine - July 2021Add to Favorites

Bio Spectrum Magazine - July 2021Add to Favorites

Go Unlimited with Magzter GOLD

Read Bio Spectrum along with 8,500+ other magazines & newspapers with just one subscription  View catalog

1 Month $9.99

1 Year$99.99 $49.99

$4/month

Save 50% Hurry, Offer Ends in 6 Days
(OR)

Subscribe only to Bio Spectrum

1 Year $10.99

Save 7%

Buy this issue $0.99

Gift Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Verified Secure
Payment

In this issue

LAB AUTOMATION
TRAVAILS IN INDIA
Whether it is the industry or academia, life sciences workers are gradually accepting the fact
that lab data digitisation improves processes, simplifies workflows and makes research and development (R&D) more efficient. With increasing advances in machine learning (ML) and artificial intelligence (AI), digitisation in the research environment is set to become an integral part of every laboratory worldwide. But in emerging markets such as India, there are a large number of factors responsible for its slow adoption such as lack of skilled workforce, high maintenance and service costs, limited expertise, data security etc.

India proposes BRICS Consortium to tackle NCDs as flagship programme

Experts deliberated on emerging issues in the various fields of Biotechnology and Biomedicine at the fourth BRICS Working Group meeting on the subject area.

India proposes BRICS Consortium to tackle NCDs as flagship programme

1 min

Govt pays Biological E Rs 1500 Cr for 30 Cr vaccines

Union Ministry of Health has finalised arrangements with Hyderabad-based vaccine manufacturer Biological E to reserve 30 crores of COVID-19 vaccine doses.

Govt pays Biological E Rs 1500 Cr for 30 Cr vaccines

1 min

Biological E, Canadian firm to jointly manufacture mRNA vaccines in India

Canadian firm Providence Therapeutics Holdings Inc. and Hyderabad-based Biological E have announced the execution of a term sheet that sets forth the material terms for a definitive licensing and collaboration agreement.

Biological E, Canadian firm to jointly manufacture mRNA vaccines in India

1 min

BDR Pharma launches affordable drug to treat ovarian, prostate cancers

Mumbai-based BDR Pharmaceutical has launched BDPARIB (RUCAPARIB) to treat advanced ovarian and prostate cancers

BDR Pharma launches affordable drug to treat ovarian, prostate cancers

1 min

Zydus Introduces New Feature In Drug Packaging To Avoid Counterfeiting

Zydus Cadila has introduced a new feature called Zydus Verify in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited.

Zydus Introduces New Feature In Drug Packaging To Avoid Counterfeiting

1 min

Stride Ventures leads Rs 25 Cr debt round in MediBuddy

Stride Ventures, one of India’s leading venture debt funds, has led a debt round of Rs 25 crore in Bengaluru-based startup MediBuddy that helps its users consult specialist doctors, order medicines and book lab tests from the comfort of their homes.

Stride Ventures leads Rs 25 Cr debt round in MediBuddy

1 min

LAB AUTOMATION - TRAVAILS IN INDIA

Whether it is the industry or academia, life sciences workers are gradually accepting the fact that lab data digitisation improves processes, simplifies workflows and makes research and development (R&D) more efficient. With increasing advances in machine learning (ML) and artificial intelligence (AI), digitisation in the research environment is set to become an integral part of every laboratory worldwide. But in emerging markets such as India, there are a large number of factors responsible for its slow adoption such as lack of skilled workforce, high maintenance and service costs, limited expertise, data security etc.

LAB AUTOMATION - TRAVAILS IN INDIA

10+ mins

‘‘We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions''

US-based Abbott Informatics, formerly known as STARLIMS, is one of the companies with a long and established presence in the space of lab automation. Taking pride in offering the world class technological solutions, the company has recently announced the launch of STARLIMS Quality Manufacturing Solution QM12.2 which is built on the latest STARLIMS Technology V12 platform, along with STARLIMS SDMS (Scientific Data Management System) V12.2. To find out more about the company’s automated offerings in India, BioSpectrum spoke to Pradeep Nagisetty, Regional Sales Manager - India & Sub Continent, Abbott Informatics - STARLIMS, Hyderabad.

5 mins

Pandemic Sets New Benchmarks For Early-Stage Healthcare Startups

The COVID-19 pandemic has been an enabler of this change as care-delivery models had to be quickly revamped to address two concerns – the diseases and the impacts of the virus on the treatment of other diseases. We aim to assess the qualitative and quantitative impact of COVID-19 and other macroeconomic events on the startup ecosystem over the last few years and try to understand the implications for the future.

Pandemic Sets New Benchmarks For Early-Stage Healthcare Startups

5 mins

‘Juvenile Idiopathic Arthritis' remains a puzzle

LET'S TALK HEALTH & SCIENCE

‘Juvenile Idiopathic Arthritis' remains a puzzle

3 mins

Read all stories from Bio Spectrum

Bio Spectrum Magazine Description:

PublisherMM Activ Sci-Tech Communication

CategoryBusiness

LanguageEnglish

FrequencyMonthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeCancel Anytime [ No Commitments ]
  • digital onlyDigital Only
MAGZTER IN THE PRESS:View All